tryptanthrine has been researched along with 1-methyltryptophan in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, F; Kuang, C; Li, X; Li, Y; Yan, J; Yang, Q; Yang, S; Yang, Y | 1 |
| Guo, Z; Hu, N; Kuang, C; Li, J; Li, Y; Yang, D; Yang, Q | 1 |
| Fang, X; Hu, H; Huang, Q; Kuang, C; Qi, F; Yang, D; Yang, Q; Zhang, S | 1 |
3 other study(ies) available for tryptanthrine and 1-methyltryptophan
| Article | Year |
|---|---|
Discovery of tryptanthrin derivatives as potent inhibitors of indoleamine 2,3-dioxygenase with therapeutic activity in Lewis lung cancer (LLC) tumor-bearing mice.
Topics: Animals; Antineoplastic Agents; Carcinoma, Lewis Lung; Dose-Response Relationship, Drug; Drug Discovery; Enzyme Inhibitors; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Lung Neoplasms; Mice; Molecular Structure; Quinazolines; Structure-Activity Relationship; Xenograft Model Antitumor Assays | 2013 |
Establishment of a human indoleamine 2, 3-dioxygenase 2 (hIDO2) bioassay system and discovery of tryptanthrin derivatives as potent hIDO2 inhibitors.
Topics: Clinical Enzyme Tests; Enzyme Inhibitors; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Inhibitory Concentration 50; Quinazolines; Recombinant Proteins | 2016 |
Tryptophan 2,3-dioxygenase inhibitory activities of tryptanthrin derivatives.
Topics: Dose-Response Relationship, Drug; Enzyme Inhibitors; HEK293 Cells; Humans; Molecular Structure; Quinazolines; Recombinant Proteins; Structure-Activity Relationship; Tryptophan Oxygenase | 2018 |